Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-22

Clinical Trial Update: Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Cameroon [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)
  • Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)

Snippet

Sponsor: University of Yaounde 1 | Conditions: Malaria | Phase 4 | Status: UNKNOWN